Gossamer Bio, 7.5% 1jul2030, USD (Conv.) (FIGI BBG022XDBB65)
国内債券, 転換社債, Senior Secured
国内債券, 転換社債, Senior Secured
|
Gossamer Bio is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutics in the disease areas of immunology, inflammation and oncology.
|
|
|
|
|
|
|
|
|
最も包括的なデータベースを探索
1 000 000
債券
80 234
株
167 970
ETF&投資信託
70 000
インデックス
最も効率的な方法でポートフォリオを追跡